Friess H - Search Results

1

Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.

Zhang C, Beckermann B, Kallifatidis G, Liu Z, Rittgen W, Edler L, Büchler P, Debatin KM, Büchler MW, Friess H, Herr I. Zhang C, et al. Among authors: friess h. Int J Oncol. 2006 Nov;29(5):1295-301. Int J Oncol. 2006. PMID: 17016664

2

Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formation.

Li J, Kleeff J, Giese N, Büchler MW, Korc M, Friess H. Li J, et al. Among authors: friess h. Int J Oncol. 2004 Jul;25(1):203-10. Int J Oncol. 2004. PMID: 15202007

3

Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy.

Büchler P, Reber HA, Eibl G, Roth MA, Büchler MW, Friess H, Isacoff WH, Hines OJ. Büchler P, et al. Among authors: friess h. Int J Oncol. 2005 Oct;27(4):1125-30. Int J Oncol. 2005. PMID: 16142331

4

Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.

Schneider M, Büchler P, Giese N, Giese T, Wilting J, Büchler MW, Friess H. Schneider M, et al. Among authors: friess h. Int J Oncol. 2006 Apr;28(4):883-90. Int J Oncol. 2006. PMID: 16525637

5

Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.

Zhang C, Kolb A, Büchler P, Cato AC, Mattern J, Rittgen W, Edler L, Debatin KM, Büchler MW, Friess H, Herr I. Zhang C, et al. Among authors: friess h. BMC Cancer. 2006 Mar 15;6:61. doi: 10.1186/1471-2407-6-61. BMC Cancer. 2006. PMID: 16539710 Free PMC article.

6

A new tool for experimental tumour research.

Zhang C, Gassler N, Schnabel PA, Dienemann H, Kolb A, Buchler P, Buchler M, Friess H, Herr I. Zhang C, et al. Among authors: friess h. Oncol Rep. 2006 May;15(5):1153-5. Oncol Rep. 2006. PMID: 16596178

7

Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids.

Herr I, Gassler N, Friess H, Büchler MW. Herr I, et al. Among authors: friess h. Apoptosis. 2007 Feb;12(2):271-91. doi: 10.1007/s10495-006-0624-5. Apoptosis. 2007. PMID: 17191112 Review.

8

Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.

Zhang C, Wenger T, Mattern J, Ilea S, Frey C, Gutwein P, Altevogt P, Bodenmüller W, Gassler N, Schnabel PA, Dienemann H, Marmé A, Hohenfellner M, Haferkamp A, Pfitzenmaier J, Gröne HJ, Kolb A, Büchler P, Büchler M, Friess H, Rittgen W, Edler L, Debatin KM, Krammer PH, Rutz HP, Herr I. Zhang C, et al. Among authors: friess h. Cancer Biol Ther. 2007 Feb;6(2):278-87. doi: 10.4161/cbt.6.2.3652. Epub 2007 Feb 27. Cancer Biol Ther. 2007. PMID: 17224649

9

Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.

Shi X, Liu S, Kleeff J, Friess H, Büchler MW. Shi X, et al. Among authors: friess h. Oncology. 2002;62(4):354-62. doi: 10.1159/000065068. Oncology. 2002. PMID: 12138244

10

The proteasome inhibitor MG132 induces apoptosis in human pancreatic cancer cells.

Wente MN, Eibl G, Reber HA, Friess H, Büchler MW, Hines OJ. Wente MN, et al. Among authors: friess h. Oncol Rep. 2005 Dec;14(6):1635-8. Oncol Rep. 2005. PMID: 16273269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,216 results

Search Page